We gratefully acknowledge the sponsorship of the following organizations:
Platinum sponsors
PFIZER
Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com.
In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Diamond sponsors
ABBVIE
AbbVie is a global research-driven biopharmaceutical company with a mission to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas—immunology, oncology, neuroscience, and eye care—and products and services in our Allergan Aesthetics portfolio. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
For more information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on LinkedIn, Facebook, Instagram,X (formerly Twitter), and YouTube.
Gold sponsor
GALDERMA
Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market though Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story.
LEO PHARMA
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark, serving millions of patients across the world.
LILLY
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
To learn more about Lilly, please visit us at: lilly.com and newsroom.lilly.com/social-channels or follow us on Facebook, Instagram, Twitter and LinkedIn.
SANOFI
Sanofi is driven by science and the patients whose health and well-being depend on us. Our purpose is to bring hope, relief and cures to patients around the world by researching, developing and manufacturing medicines and vaccines, and by accelerating access to scientific innovation. The specialty care global business unit of Sanofi focuses on immunology, respiratory, dermatology, rare diseases, rare blood disorders and multiple sclerosis. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialised treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Web: www.sanofi.com.au + Social Media Links: Facebook / X / LinkedIn / Instagram / YouTube
Silver sponsor
PIERRE FABRE ECZEMA FOUNDATION
The Pierre Fabre Eczema Foundation collaborates with healthcare professionals and supports patients so they can join forces to help patients live better with eczema. Its missions: by offering support and creating collaborations, we aim to ease the burden on patients. Our primary mission is to support various groups: To provide support and assistance for patients to help them take, control of their disease; to provide patients and healthcare professionals with opportunities to join forces; to train and bring together healthcare professionals and academics; to help experts reach a consensus on how to approach eczema so that it may be shared and understood by all; to share knowledge and raise awareness about eczema; to contribute to eczema research. Our values and philosophy: Sharing – Sharing knowledge, expertise, experiences, networks, and resources; Listening, support and empathy – Providing support and understanding so that everyone can find what they are looking for; Ethics – Adopting the ethical approach unique to the Pierre Fabre Group: high standards combined with a human consideration; Openness to others – By broadening the scope of treatment and by opening up to as many people as possible.
Bronze sponsors
CERAMOL / UNIFARCO
Ceramol is the dermatological brand of Unifarco, an Italian company established in 1982 and located at the foot of the Belluno Dolomites National Park. It has studied the skin barrier for more than 20 years, coming up with new solutions for atopic, allergic and reactive skin working closely with dermatologists, university researchers and pharmacists.
Ceramol products stand for the effective care of the skin barrier enabling improved quality of life for people of all ages with demanding skin or skin diseases like atopic eczema. Continuous interdisciplinary research results in this minimalistic product line based on a crucial ratio of epidermal lipids and active ingredients which help restore the skin defences and rebuild the epidermal barrier.
Ceramol counts dermatological cosmetics and medical devices to treat dermatitis, especially atopic dermatitis, reactive and allergic skin, besides psoriasis and acne.
For more information about Ceramol visit us at ceramol.com.
Follow Ceramol on Instagram and YouTube.